Global law firms Arnall Golden Gregory LLP, and Taylor Wessing, together with AGG Food & Drug, are planning to host a complimentary webinar on September 20th, between 11:00 am and 12:15 pm EDT. The topic on the docket for this session will be an exploration of the regulatory landscape of clinical trial agreements in both the EU and the U.S.
This is a long-awaited conversation, a subject that has several challenges and opportunities for legal professionals working in large corporations and law firms. The webinar will provide an explorative assessment of the EU and FDA issues that could arise when dealing with clinical trials and clinical agreements.
Co-chair of AGG Food & Drug, Alan G. Minsk, as well as Taylor Wessing Life Sciences and Healthcare attorneys Dr. Manja Epping and Irina Rebin, are expected to lead the session. Their combined expertise on both European Union and U.S. regulations will bring valuable insights to the participants of this webinar.
While the specifics of the talk remain to be revealed, attendees can expect a comprehensive discussion on the complex legal aspects of conducting clinical trials. This will likely include elements like contract terms, ethical considerations, data privacy issues, and challenges associated with conducting studies across borders. Importantly, the webinar will aim to provide a better understanding of the legal scenarios one could face when dealing with clinical trials and agreements within the realm of FDA and EU regulations.
For those interested in attending, further details and means to RSVP may be found in the original webinar announcement at JD Supra. Be sure to mark your calendars for this exciting opportunity to gain insights from industry experts on a highly relevant topic in today’s global legal landscape.